Three-dimensional imaging could provide equivalent image quality to 2D acquisitions in T2-weighted imaging of the prostate at 3T.
Three-dimensional acquisitions provide equivalent image and lesion delineation quality, compared to 2D in T2-weighted imaging of the prostate, according to a study published in the journal European Radiology.
Researchers from Austria performed a prospective study to determine if 3D acquisitions could provide equivalent image quality, lesion delineation quality and PI-RADS v2 performance compared to 2D acquisitions in T2-weighted imaging of the prostate at 3 T.
One hundred fifty patients (mean age 63.7 years; mean PSA 7.2 ng/ml) participated in the study. Two uroradiologists independently rated image quality and lesion delineation quality using a five-point ordinal scale and assigned a PI-RADS score for 2D and 3D T2-weighted image data sets. Data were compared using visual grading characteristics (VGC) and receiver operating characteristics (ROC)/area under the curve (AUC) analysis.
The results demonstrated equivalent image and delineation quality, and PI-RADS v2 performance, compared to 2D in T2-weighted imaging of the prostate.
Reader 1/Reader 2
Image quality for 2D T2w
Mean score: 4.3 ± 0.81/Mean score:4.7 ± 0.83
Image quality for 3D T2w
Mean score: 4.3 ± 0.82/Mean score:4.7 ± 0.69
Lesion delineation for 2D T2w
4.16 ± 0.81/4.19 ± 0.92
Lesion delineation for 3D T2w
4.19 ± 0.94/4.27 ± 0.94
ROC analysis showed an equivalent performance for 2D (AUC 0.580–0.623) and 3D (AUC 0.576–0.629) T2w.
The researchers concluded that three-dimensional T2-weighted imaging could be used to considerably shorten prostate MRI protocols in clinical practice.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.
Could an Emerging AI System Lead to Earlier Autism Detection with DT-MRI?
November 21st 2023Through assessment of diffusion tensor MRI of the brain, a new AI system reportedly offers a 97 percent sensitivity rate in diagnosing autism in children between two to four years of age, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.
New Dual-Source CT Device May be Cost-Effective Alternative for Smaller Facilities
November 16th 2023Offering a combination of simplified and personalized scanning for patients at significantly lower lifecycle costs than other dual-source CT systems, the Somatom Pro.Pulse may be a viable option for smaller rural facilities and outpatient imaging centers.